Page last updated: 2024-10-31

mianserin and Dyspnea

mianserin has been researched along with Dyspnea in 2 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Dyspnea: Difficult or labored breathing.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jensen, JB1

Other Studies

2 other studies available for mianserin and Dyspnea

ArticleYear
Adverse Drug Reactions Advisory Committee: ADRAC report for 1980.
    The Medical journal of Australia, 1982, May-15, Volume: 1, Issue:10

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Australia; Bronchial Spasm; Chemical and Drug Induced Live

1982
[Edema tendency, dyspnea and hypertension in the treatment with mirtazapine (Remeron)].
    Ugeskrift for laeger, 1999, May-03, Volume: 161, Issue:18

    Topics: Adrenergic alpha-Antagonists; Adult; Antidepressive Agents, Tricyclic; Dyspnea; Edema; Female; Hista

1999